Intelligent Bio Solutions Net Acquisitions/Divestitures 2020-2025 | INBS

Intelligent Bio Solutions net acquisitions/divestitures from 2020 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.

Intelligent Bio Solutions Net Acquisitions/Divestitures 2020-2025 | INBS

Intelligent Bio Solutions net acquisitions/divestitures from 2020 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$143.6B
CVS Health (CVS)$83.1B
Elevance Health (ELV)$66.2B
Cencora (COR)$55.3B
DiDi Global (DIDIY)$26.1B
Labcorp Holdings (LH)$22.1B
Natera (NTRA)$20.7B
BioMerieux (BMXMF)$17.7B
EUROFINS SCIENT (ERFSF)$14.9B
CochLear (CHEOY)$13.2B
ICON (ICLR)$12.8B
Solventum (SOLV)$12.7B
Medpace Holdings (MEDP)$12.2B
Viatris (VTRS)$11.4B
Revvity (RVTY)$10.1B
Sonic Healthcare (SKHHY)$9B
HealthEquity (HQY)$8B
Avantor (AVTR)$7.8B
Caris Life Sciences,�Inc (CAI)$7.6B
Charles River Laboratories (CRL)$7.3B
Bausch + Lomb (BLCO)$4.8B
Sotera Health (SHC)$4B
Amplifon S.p.A (AMFPF)$3.9B
BrightSpring Health Services (BTSG)$3.7B
Surgery Partners (SGRY)$3B
GeneDx Holdings (WGS)$3B
Alignment Healthcare (ALHC)$2.9B
Concentras Parent (CON)$2.8B
Organon (OGN)$2.4B
Progyny (PGNY)$2B